Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, California.
Department of Orthopaedic Surgery, Stanford University, Palo Alto, California.
Pain Med. 2017 Jul 1;18(7):1326-1333. doi: 10.1093/pm/pnw264.
The challenge of obtaining medical imaging in individuals with higher body mass index (BMI) is described, but there is minimal data regarding the relationship between BMI and fluoroscopy time during cervical interlaminar epidural steroid injection (CIESI).
To determine the relationship between BMI and fluoroscopy time during CIESI.
Retrospective cohort study of patients who underwent fluoroscopically guided CIESI between January 2014 and February 2015 at an academic pain medicine center. Fluoroscopy time data were collected. Comparisons based on analysis of variance were made between patients with normal (<25.0 kg/m 2 ), overweight (25.0-29.9 kg/m 2 ), and obese (≥30.0 kg/m 2 ) BMI.
Of 399 procedure encounters, 366 had documented BMI and fluoroscopy time data and were included for analysis. Mean age (± SD) in this cohort was 53 ± 13 years, including 189 females (52%) and 205 first-time injections. Mean fluoroscopy time for all injections was 18 ± 10 seconds. Separated by categorical BMI class, the mean fluoroscopy time was 18 ± 9 seconds for normal weight patients, 17 ± 10 seconds for overweight patients, and 20 ± 11 seconds for obese patients, respectively. Post hoc analysis showed that fluoroscopy time was significantly longer only in obese compared with overweight patients ( P = 0.02). Trainee involvement and first-time vs repeat injection did not significantly alter fluoroscopy time ( P = 0.17 and P = 0.12, respectively).
The findings of this study indicate that BMI does not appear to have a clinically significant impact on fluoroscopy time during cervical interlaminar epidural steroid injection procedures. Future study is needed to directly quantify radiation exposure in patients and practitioners, as well as the associated health risk.
描述了在体重指数(BMI)较高的个体中获取医学成像的挑战,但关于 BMI 与颈椎间硬膜外类固醇注射(CIESI)过程中的透视时间之间的关系的数据很少。
确定 BMI 与 CIESI 过程中的透视时间之间的关系。
对 2014 年 1 月至 2015 年 2 月在学术疼痛医学中心进行荧光镜引导下 CIESI 的患者进行回顾性队列研究。收集透视时间数据。在 BMI 正常(<25.0kg/m 2 )、超重(25.0-29.9kg/m 2 )和肥胖(≥30.0kg/m 2 )的患者之间,基于方差分析进行比较。
在 399 次手术中,有 366 次记录了 BMI 和透视时间数据,并纳入分析。该队列的平均年龄(±标准差)为 53±13 岁,包括 189 名女性(52%)和 205 名初次注射者。所有注射的平均透视时间为 18±10 秒。按 BMI 分类,正常体重患者的平均透视时间为 18±9 秒,超重患者为 17±10 秒,肥胖患者为 20±11 秒。事后分析显示,仅肥胖患者的透视时间明显长于超重患者(P=0.02)。学员参与和初次注射与重复注射对透视时间没有显著影响(P=0.17 和 P=0.12)。
本研究结果表明,BMI 似乎不会对颈椎间硬膜外类固醇注射过程中的透视时间产生显著影响。需要进一步研究直接量化患者和医生的辐射暴露以及相关健康风险。